Precigen Inc [NASDAQ: PGEN] gained 11.76% or 0.2 points to close at $1.9 with a heavy trading volume of 9419707 shares.
It opened the trading session at $1.74, the shares rose to $2.04 and dropped to $1.74, the range by which the price of stock traded the whole day. The daily chart for PGEN points out that the company has recorded 58.33% gains over the past six months.
If we look at the average trading volume of 1.67M shares, PGEN reached to a volume of 9419707 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Precigen Inc [PGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PGEN shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PGEN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Precigen Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on March 22, 2024. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on May 23, 2023, representing the official price target for Precigen Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on PGEN stock.
Trading performance analysis for PGEN stock
Precigen Inc [PGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 31.03. With this latest performance, PGEN shares gained by 26.67% in over the last four-week period, additionally plugging by 58.33% over the last 6 months – not to mention a rise of 69.64% in the past year of trading.
Precigen Inc [PGEN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Precigen Inc [PGEN] shares currently have an operating margin of -2211.16% and a Gross Margin at -53.65%. Precigen Inc’s Net Margin is presently recorded at -3728.87%.
Return on Equity for this stock declined to -118.84%, with Return on Assets sitting at -118.84%.
An analysis of Institutional ownership at Precigen Inc [PGEN]
There are presently around $67.05%, or 74.93% of PGEN stock, in the hands of institutional investors. The top three institutional holders of PGEN stocks are: PATIENT CAPITAL MANAGEMENT, LLC with ownership of 18.17 million shares, which is approximately 7.2017%. BLACKROCK INC., holding 10.25 million shares of the stock with an approximate value of $$16.19 million in PGEN stocks shares; and BLACKROCK INC., currently with $$10.68 million in PGEN stock with ownership which is approximately 2.6784%.
